Jeremiah McDole

Oncology Segment Manager of the Digital Biology Group at Bio-Rad Laboratories

Content by Jeremiah McDole:

Diagnostics Biochemistry and molecular biology

Raising the Bar in MRD Testing

09/30/2022 | Jeremiah McDole | 4 min read

Minimal residual disease testing could help more patients beat cancer – but first, we need tests that are precise, sensitive, and accurate enough

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Pathologist magazine